Projects per year
Ovarian cryopreservation rapidly developed from basic science to clinical application and can now be used to preserve the fertility of girls and young women at high risk of sterility. Primordial follicles can be cryopreserved in ovarian cortex for long-term storage and subsequently autografted back at an orthotopic or heterotopic site to restore fertility. However, autografting carries a risk of re-introducing cancer cells in patients with blood-born leukaemias or cancers with a high risk of ovarian metastasis. For these women fertility restoration could only be safely achieved in the laboratory by the complete in vitro growth (IVG) and maturation (IVM) of cryopreserved primordial follicles to fertile metaphase II (MII) oocytes. Culture systems to support the development of human oocytes have provided greater insight into the process of human oocyte development as well as having potential applications within the field of fertility preservation. The technology required to culture human follicles is extremely challenging, but significant advances have been made using animal models and translation to human. This review will detail the progress that has been made in developing human in vitro growth systems and consider the steps required to progress this technology towards clinical application.
|Publication status||Published - 30 Nov 2019|
FingerprintDive into the research topics of 'Progress and prospects for developing human immature oocytes in vitro'. Together they form a unique fingerprint.
- 2 Finished
Exploration of the oogenic potential of putative germ line stem cells isolated from the ovaries of girls and adult women
1/10/17 → 31/05/21
Developmental and meiotic potential of oocytes derived from human ovarian germ line stem cells (OSCs) in vitro
1/11/13 → 28/05/16